Fabry Disease
Fabry Disease
Also known as:Fabry Disease, Anderson-Fabry Disease, Alpha-Galactosidase A Deficiency
Fabry Disease is an X-linked lysosomal storage disorder that can affect the nervous system, skin, kidneys, heart, cerebral blood vessels, eyes, and gastrointestinal tract, often leading to delayed diagnosis due to symptoms spread across multiple systems.
Start Here
A quick guide to the next step: which department to start with, what to prepare, and what to ask.
When adolescents or adults have burning pain in the hands and feet, reduced or absent sweating, angiokeratomas, corneal whorl-like opacities, unexplained proteinuria, left ventricular hypertrophy, or stroke at a young age, consider starting with nephrology, cardiology, neurology, or genetic/metabolic/rare disease clinics.
Variants in the GLA gene cause reduced alpha-galactosidase A enzyme activity, leading to accumulation of glycolipid substances within cells, which progressively affects the nervous system, kidneys, heart, and cerebral blood vessels.
Yes, there are specific treatments and organ-protective management options available, but whether treatment is suitable, when to start, and how to monitor require a specialist team to evaluate genetic results, enzyme activity, organ involvement, and local access to care.
Yes, X-linked inheritance. Men are typically affected earlier and more severely, but women can also develop significant symptoms due to variation in X chromosome inactivation.
Pain, gastrointestinal, skin, heart, kidney, and cerebrovascular symptoms often appear in different specialties. Women or people with later-onset presentations may have atypical features, making it easier for the condition to go unrecognized for years.
Common Search and Care Questions
This page helps patients and families organize care leads. It does not replace a clinician’s diagnosis or treatment plan. For testing, medication, referrals, emergency care, and support applications, follow qualified clinicians, medical institutions, support organizations, and official sources.
Diagnosis Path
Organized around the practical patient journey: identify clues, avoid common delays, then prepare for care.
When to Suspect It
- Pain with a burning sensation in the hands and feet starting in childhood or adolescence, worsening with heat, exercise, or fever, accompanied by reduced or absent sweating.
- Skin angiokeratomas, especially on the trunk, groin, buttocks, or upper thighs.
- Unexplained proteinuria, declining kidney function, left ventricular hypertrophy, heart rhythm abnormalities, or stroke/TIA at a young age.
- Corneal whorl-like opacities found during eye exam, together with pain, kidney, or heart-related clues.
- Family history of males with early-onset kidney failure, heart disease, or stroke, or a known GLA variant in the family.
Common Wrong Turns
- Extremity pain managed long-term as rheumatism, nerve pain, or growing pains.
- Proteinuria, heart muscle thickening, and stroke seen in separate visits, without asking about skin, sweating, pain, and family history.
- Fabry disease fully ruled out in women after enzyme activity comes back normal, without considering genetic testing and clinical findings.
- Focusing only on specific treatments, while neglecting long-term management of kidney, heart, brain, and psychosocial support.
Departments to Start With
- Nephrology
- Cardiology
- Neurology
- Dermatology/Ophthalmology (when identifying clues)
- Genetics/Medical Genetics/Rare Disease Clinic
Before the Visit
- Document pain, sweating, skin rash, gastrointestinal symptoms, hearing, vision, kidney, heart, and cerebrovascular symptoms.
- Gather urine protein, kidney function, ECG, cardiac ultrasound/MRI, brain MRI, ophthalmology, and dermatology findings.
- For males, ask about alpha-Gal A enzyme activity testing; for females or complex cases, focus on GLA genetic testing.
- Ask your doctor to explain whether the GLA variant is disease-causing, and whether family screening is needed.
- Confirm baseline organ involvement and follow-up plans for kidneys, heart, and brain.
Tests to Ask About
- Alpha-galactosidase A enzyme activity testing.
- GLA genetic testing and family cascade screening.
- Lyso-Gb3/related biomarkers (when your doctor considers it appropriate).
- Urine protein, eGFR, kidney assessment.
- ECG, Holter monitoring, cardiac ultrasound, or cardiac MRI.
- Brain MRI, slit-lamp eye exam, hearing test, and neuropathic pain assessment.
Questions for the Doctor
- Does my presentation fit classic or later-onset Fabry Disease? What is the evidence?
- How do I interpret my GLA variant? Who in my family should be screened first?
- Which organs are currently affected? How often do I need follow-up?
- Is specific treatment appropriate for me? What are the treatment goals and monitoring targets?
- How will pain, kidney, heart, stroke risk, and psychological stress be managed?
Basic Information
Medical Notes
More complete medical explanations are kept here for discussion with clinicians.
Symptoms
Fabry Disease can present with burning pain in the hands and feet, reduced or absent sweating, angiokeratomas, corneal whorl-like opacities, abdominal pain or diarrhea, hearing loss, proteinuria or declining kidney function, left ventricular hypertrophy, heart rhythm abnormalities, chest pain, stroke at a young age, or white matter changes. Classic-type males are usually affected earlier, while females and later-onset types may have more subtle symptoms.
Diagnosis
Diagnosis requires combining clues from multiple systems, family history, alpha-galactosidase A enzyme activity, GLA genetic testing, and organ assessments. Reduced enzyme activity in males is highly suggestive; females may have normal enzyme activity, so enzyme testing alone cannot rule out the disease. Genetic results need to be interpreted in the context of clinical features and databases.
Treatment
Treatment includes specific therapies, kidney and cardiovascular protection, pain management, stroke risk management, gastrointestinal and psychosocial support. Decisions about enzyme replacement, pharmacological chaperones, or other options should be made by a team familiar with Fabry Disease, based on the disease type, organ involvement, and access to care.
Long-term Care
Long-term follow-up usually requires collaboration among nephrology, cardiology, neurology, ophthalmology, dermatology, and genetic counseling. Key monitoring includes urine protein/eGFR, heart structure and rhythm, cerebrovascular risk, pain, hearing, quality of life, and progress with family screening.
Fertility and Family
Fabry Disease is X-linked. A male patient will pass the GLA variant to all daughters but not to sons; a female patient has approximately a 50% chance of passing the variant to each child. When planning a pregnancy, genetic counseling can explain options such as prenatal diagnosis or preimplantation genetic testing.
When to Seek Urgent Care
Sudden weakness on one side, difficulty speaking, severe chest pain, fainting, severe palpitations, acute shortness of breath, significantly reduced urine output, or rapid worsening of kidney function require immediate emergency care. Be sure to tell doctors that Fabry Disease is suspected or confirmed and inform them of any previous heart, kidney, or cerebrovascular involvement.
Prognosis
Early identification and monitoring of organ involvement can help reduce irreversible damage; prognosis depends on disease type, timing of treatment, and the extent of heart, kidney, and cerebrovascular involvement.